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Abstract
Background: We studied the incidence of withholding or withdrawing therapeutic measures in
intensive care unit (ICU) patients, as well as the possible implications of sepsis-related organ failure
assessment (SOFA) in the decision-making process and the ethical conflicts emerging from these
measures.
Methods: The patients (n = 372) were placed in different groups: those surviving 1 year after ICU
admission (S; n = 301), deaths at home (DH; n = 2), deaths in the hospital after ICU discharge (DIH;
n = 13) and deaths in the ICU (DI; n = 56). The last group was divided into the following subgroups:
two cardiovascular deaths (CVD), 20 brain deaths (BD), 25 deaths after withholding of life support
(DWH) and nine deaths after withdrawal of life support (DWD).
Results: APACHE III, daily therapeutic intervention scoring system (TISS) and daily SOFA scores were
good mortality predictors. The length of ICU stay in DIH (20 days) and in DWH (14 days) was
significantly greater than in BD (5 days) or in S (7 days). The number of days with a maximum SOFA
score was greater in DWD (5 days) than in S, BD or DWH (2 days).
Conclusions: Daily SOFA is a useful parameter when the decision to withhold or withdraw treatment
has to be considered, especially if the established measures do not improve the clinical condition of
the patient. Although making decisions based on the use of severity parameters may cause ethical
problems, it may reduce the anxiety level. Additionally, it may help when considering the need for
extraordinary measures or new investigative protocols for better management of resources.
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Introduction
In 1990, Smedira et al[1] wrote that ` life support is withheld
or withdrawn from many patients especially those with crit-
ical illness, but the exact number is not known'. The terms
`withholding of life support' and `withdrawal of life support'
refer to the process according to which various medical
interventions either are not given or are removed from
patients with the expectation that they will die as a result.
The feeling that a patient admitted to the intensive care unit
(ICU) should not be considered as a `terminal patient' [2]
produces difficulties in rationalizing the use of new and
costly technologies in a situation where resources are
scarce, such as the modern healthcare systems [3]. This
has led to the development of new systems for the assess-
ment of severity for use in the ICU. These tools may be used
to predict outcome, although their use has ethical and
financial implications [4,5].
Over the last 15 years, several systems for the assessment
of multiorgan failure have been developed [6–12], mainly
because infections and multiorgan failure represent the
main cause of mortality and morbidity among critically ill
patients managed in the ICU [6]. This study was designed
to combine severity scoring with information about the
benefits and costs related to the use of the therapeutic
intervention scoring system (TISS) [13–15].
The objectives of the study were:
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ing care in critically ill patients in a multidisciplinary adult
Spanish ICU.
2. To evaluate whether decisions made about withholding
or withdrawal of treatment and applying a pre-established
protocol could be supported by the information obtained
from the monitoring of indicators of severity, in other words
sepsis-related organ failure assessment (SOFA) [6], TISS
[16], and APACHE III [17].
3. To analyze the ethical conflicts emerging during the
study period.
4. To decrease the level of anxiety among family members
and the medical team responsible for the patient's care, at
the time when the decision is taken to withhold or to with-
draw therapeutic management [18].
Methods
Before the study was started, deaths among patients
admitted to the ICU were defined in relation to the type of
management before death [19].
Definitions
The patients were placed in groups according to the final
outcome: those surviving 1 year after ICU admission (S);
death at home after hospital discharge (DH); death in the
hospital once discharged from the ICU (DIH); and death in
the ICU (DI).
In the DI group, the cases were classified into the following
subgroups according to the type of management decision
taken at the time of death.
Cardiovascular death (CVD): those patients who died
despite cardiopulmonary resuscitation (CPR) [20] for at
least 30 min, according to hospital guidelines. This group
represents a substantial investment in therapeutic
resources at the time of death.
Brain death (BD): those patients where an irreversible loss
of cerebral and brainstem function were found, following
the guidelines of the Spanish Society of Neurology [21]
and of Spanish law [22]. This group represents a large
investment in diagnostic resources at the moment of death.
Once BD was confirmed, mechanical ventilation was with-
drawn or was continued until organ donation was
authorized.
Death after withholding of life support (DWH; patients in
whom it was decided to limit therapy): the most common
therapies withheld are CPR in the event of cardiac arrest
and dialysis. Less frequently withheld therapeutic measures
are mechanical ventilation, laboratory analysis, surgical pro-
cedures, administration of antibiotics, parenteral nutrition,
blood transfusions, fluid therapy, antiarrhythmic drugs or
vasopressors. In our ICU, the withholding of any therapeu-
tic measure besides CPR and dialysis is rare, because
either these cases would not be considered to be candi-
dates for admission into the ICU [19], or the withdrawal of
therapeutic measures of life support would be considered.
Death after the withdrawal of therapeutic life-support
measures (DWD; patients in whom a gradual withdrawal
of therapeutic resources of life support was carried out,
after the previous establishment of withholding measures):
initially, nutrition, vasopressor agents and dialysis were
withdrawn. Finally, oxygen support was withdrawn and, if
necessary, the respiratory frequency and the tidal volume
were reduced [24]. The patient was never disconnected
from mechanical ventilation, nor was sedation stopped in
any case.
Decision-making process
The medical team considered the withholding or withdraw-
ing of treatment in each patient without having knowledge
of the analyzed severity parameters.
The ICU doctor responsible for the patient's care, on their
own initiative or after considering a proposal from the
patient's family or the head of the department, proposed the
need to establish therapeutic restrictions or to withdraw
treatment. This opinion was discussed with the other doc-
tors of the service and the nursing staff responsible for the
patient. If the proposal was accepted, the relevant doctors
from other departments who had sought the patient's
admission to the ICU were asked for their opinion and, once
a consensus was reached, this was conveyed to the family
by the ICU doctor directly responsible for the patient.
If at any time the decision was not accepted, the required
life-support measures were continued. The ICU doctor on
call always respected the decisions reached. Only in rare
circumstances did the on-call doctor, in agreement with the
admitting doctor, decide, with the family, to withhold treat-
ment before group discussion. The decisions were docu-
mented in the patient's notes.
Once the patient was discharged to a general ward, the
ICU doctor informed the ward doctor about the decisions
taken, such as not to return to ICU in case of deterioration
in the patient's clinical condition or not to perform CPR.
Data collected
Resource utilization was evaluated by measuring the use of
mechanical ventilation and the daily TISS in the ICU. The
APACHE III on the first day and the daily SOFA were used
as indicators of severity. A SOFA score was calculated for
Available online http://ccforum.com/content/2/2/61each organ system and all scores equal to or greater than
1 were added together to give an indication of the severity
of the case. SOFA was not used in this case as an indicator
of the severity of sepsis.
APACHE III and SOFA were recorded on the first day and
also recorded were the mean SOFA value during ICU stay,
maximum SOFA score, number of days with the maximum
SOFA score, sum of all the SOFA points of the ICU stay,
TISS at the first day, mean TISS value during the stay in ICU
and sum of all the TISS points of the ICU stay.
Inclusion criteria
All patients with ICU stay longer than 24 h were included,
as were those whose stay was less than 24 h but who
needed mechanical ventilation.
Statistics
We compared the groups using the Kruskal-Wallis test and
the Mann-Whitney rank-sum test, with the Tukey-B test and
the Scheffe test correction for between-groups analysis.
The qualitative variables were analyzed with the Chi-square
test. Differences were considered significant at P < 0.05.
Groups with small samples (< 5) were excluded from the
statistical analyses. All statistical analyses were performed
on a personal computer with the SPSS®7.5 (SPSS Inc,
Chicago, Illinois, USA).
Results
A total of 623 patients were admitted to the ICU during the
study period from March to December 1995, with an over-
all mortality rate of 9% (58 cases). Two hundred and fifty-
one patients did not fulfill the inclusion criteria and were
excluded.
A total of 372 patients were included: 68% were male,
mean age (± SD) was 59 ± 17 years (range 14–92), mean
average stay in ICU was 8 ± 10 days (range 1–81) and the
1-year mortality rate was 19% (71 cases). Table 1 shows
mortality according to the patient's origin and Table 2
shows the analyzed parameters in relation to the 1-year
mortality rate.
The 1-year mortality rate increased in relation to the length
of ICU stay. It varied from 12% (15 out of 121 patients) for
stays less than 2 days, to 22% (56 out of 251) for stays
longer than 2 days (P = 0.02), and from 13% (35 out of
267) for periods shorter than 1 week to 34% (36 out of
105) for stays longer than 1 week (P = 0.001).
The mortality rate was also closely related to the need for
mechanical ventilation. Of 203 cases (55%) who required
mechanical ventilation, 66 died (32%) compared with a 3%
mortality rate in cases where mechanical ventilation was
not needed (5 out of 169; P = 0.001).
Analysis of the maximum SOFA score showed that patients
with two or less organ-system failures had a 1-year mortal-
ity rate of 2% (3 out of 180). If 3–5 organ systems were
involved, the mortality rate rose to 26% (38 out of 148). If
the respiratory, cardiovascular and neurological systems
were involved simultaneously, the mortality rate rose to
35% (35 out of 101). In patients where six organ systems
failed, the mortality rate was found to be 68% (30 out of
44). In this last group, all 16 patients reaching a maximum
SOFA score greater than 16 died.
Table 3 reflects the results of the analyzed parameters in
relation to the final outcome. For the statistical analysis,
patients from the CVD group and from the DH group were
excluded, owing to the small size of the group. Table 3
shows that, in patients who died, APACHE III (BD: 91 ± 31,
range 34–129; DWH: 84 ± 3, range 31–153; DWD: 81 ±
25, range 41–113; DIH: 91 ± 31, range 44–137) and
SOFA score on the first day (BD: 9 ± 3, range 2–16;
DWH: 9 ± 4, range 1–17; DWD: 9 ± 4, range 1–16; DIH:
10 ± 4, range 3-16) were significantly higher than in the S
group (APACHE III: 38 ± 24, range 2–117; SOFA score
on the first day: 4 ± 4, range 0–14; P  <  0.0001). The CVD
group (APACHE III: 41 ± 19, range 27–54; SOFA score
on the first day: 2 ± 3, range 0–4) had similar results to the
S group.
The TISS score on the first day is significantly higher in the
BD (34 ± 10, range 15–53), DWH (34 ± 11, range 16–57)
and DIH groups (34 ± 5, range 25–41) than in the S group
(22 ± 13, range 4–54; P  <  0.0001). There were no signif-
icant differences between the S group and the DWD (24 ±
13, range 8–46) and CVD groups (15 ± 1, range 14–16).
The mean SOFA of the S group (3 ± 3, range 0–12) and
the CVD group (4 ± 5, range 0–7) was significantly lower
than in the other groups (BD: 11 ± 3, range 5–19; DWH:
12 ± 4, range 4–18; DWD: 11 ± 4, range 7–19; DIH: 8 ±
3, range 3–11; P  <  0.0001).
Similarly the mean TISS of the S group (21 ± 11, range 4–
47) and the CVD group (21 ± 14, range 11–31) was sig-
nificantly lower than in the other groups (BD: 35 ± 9, range
22–60; DWH: 37 ± 11, range 15–59; DWD: 33 ± 7,
range 19–44; DIH: 31 ± 5, range 25–41; P  <  0.0001).
ICU stay (days) was significantly shorter in the S (7 ± 8,
range 1-58), CVD (4 ± 3, range 2–6) and BD groups (5 ±
6, range 1–20), compared with the DWH (14 ± 16, range
1–81) and DIH groups (20 ± 14, range 5–44; P  <
0.0001). There were no significant statistical differences
between the S and DWD groups (12 ± 10, range 3–29).
The accumulated SOFA of the groups with a shorter ICU
stay (S: 31 ± 58, range 0–496; CVD: 11 ± 15, range 0–Page 3 of 7
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than in the groups with a longer stay (DWH: 161 ± 151,
range 14–619; DWD: 139 ± 119, range 39–377; DIH:
168 ± 121, range 16–371; P  <  0.0001).
The accumulated TISS of the groups with a shorter ICU
stay (S: 185 ± 303, range 5–2100; CVD: 66 ± 5, range
62–69; BD: 207 ± 249, range 22–871) was significantly
lower than in the DWH (516 ± 575, range 35–2647) and
DIH groups (632 ± 437, range 123–1399; P  <  0.001),
but there were no statistically significant differences with
the DWD group (396 ± 359, range 77–1036).
The maximum SOFA was significantly lower in the S (4 ± 4,
range 0–16) and CVD groups (6 ± 8, range 0–12) com-
pared with other groups (BD: 13 ± 4, range 8–24; DWH:
15 ± 4, range 4–22; DWD: 15 ± 4, range 9–23; DIH: 11
± 4, range 3–16; P  <  0.0001). There were also significant
differences between the DWH and DIH groups (P  <
0.001).
When the number of days with maximum SOFA was ana-
lyzed, significant differences were found between the DWD
group (5 ± 9, range 1–29) and the S (2 ± 2, range 0–18),
BD (2 ± 2, range 1–9) and DWH groups (2 ± 2, range 1–
10; P  <  0.001). No significant statistical differences were
found with respect to the DIH group (3 ± 2, range 1–7).
Discussion
The aim of this study was to further the debate whether in
the future, numerical data may be useful tools to help in the
final decisions with respect to critical patients.
Leaving aside the `last bed' problem [25], this process nor-
mally implied a pre-admission interview with the patient
and/or family, who accepted the use of the required proce-
dures for the management of the critically ill patient.
The problems begin when the applied treatment does not
improve the patient's clinical condition, and the severity of
the illness and/or the use of sedation does not allow the
patient's opinion to be obtained regarding life-sustaining
treatment [26]. In this situation, communication with spe-
cialists and the family is of enormous importance [27], and
it is vital to have a clear idea about the patient's clinical con-
dition to obtain the necessary consent [1,28]. It should be
noted that delegated consent was obtained in all cases.
Our study revealed that more than 65% of patients who
died in the first year after admission to the ICU had treat-
ment withheld or withdrawn. Unlike other studies
[1,2,4,24], we differentiated between BD (28%) and DWD
(13%), given that the medical care and ethical implications
are very different in these two groups. The DWH group rep-
resented 35% of cases. While brain death caused only
Table 1
Mortality and origin
Cases [n (%)] Mortality rate
Admitted after surgical procedures 141 (38%) 13%
Referred from other medical center 105 (28%) 20%
Admitted from emergency room 63 (17%) 22%
Admitted from the general wards 63 (17%) 27%
Table 2
Indicators of severity in the population studied
Total Survivors Death
Age 59 ± 17 (14–92) 58 ± 17 (15–92) 62 ± 18 (14–86) NSD
ICU stay (days) 8 ± 10 (1–81) 7 ± 8 (1–58) 12 ± 14 (1–81) P < 0.001
APACHE III 48 ± 31 (2–153) 38 ± 24 (2–117) 86 ± 29 (27–153) P < 0.001
TISS on first day 24 ± 13 (4–57) 22 ± 13 (4–54) 32 ± 11 (8–57) P < 0.001
Accumulated TISS 232 ± 355 (5–2647) 185 ± 303 (5–2100) 434 ± 474 (22–2647) P < 0.001
SOFA on first day 5 ± 4 (0–17) 4 ± 4 (0–14) 9 ± 4 (0–17) P < 0.001
Maximum SOFA 6 ± 5 (0–24) 4 ± 4 (0–16) 13 ± 4 (0–24) P < 0.001
Accumulated SOFA 49 ± 85 (0–619) 31 ± 58 (0–496) 129 ± 127 (0–619) P < 0.001
Data are shown as mean ± SD (range). ICU, intensive care unit; TISS, therapeutic intervention scoring system; SOFA, sepsis-related organ failure 
assessment; NSD, not significantly different.
Available online http://ccforum.com/content/2/2/61occasional diagnostic difficulties, the greatest ethical con-
flicts among the medical team responsible for the patient
were caused when deciding in which patients and at what
moment should therapeutic restrictions or withdrawal of
life-supporting measures be suggested and established. In
our study, these ethical discussions arose in 48% of
patients who died.
We confirmed that SOFA as a marker of the evolution of
severity may be of great help when these problems arise.
This indicator of severity, associated with TISS, allowed us
to make a quantitative evaluation of the patient's clinical
response to the investment of resources. APACHE III and
SOFA provided valuable information which facilitated
approaches to the withholding or withdrawal of treatment,
whether in the ICU itself or once the patient has been dis-
charged to the general ward. TISS allowed an evaluation to
be made of the investment of resources.
At this point, it would be easy to generalize decision making
according to these markers, as they seem to be good indi-
cators of bad prognosis [28]. However, decisions should
be individualized for each patient, as the concepts of quality
of life and dignity in death, new technologies, greater
demand for health or the maintenance of sustainable or
equitable medicine greatly influence the decision-making
process [26,29,30].
With a follow-up based on objective and quantifiable data,
the doctor is better informed. This is fundamental when the
changes in the role of the doctor in the decision-making
process are considered. The principles of autonomy and
self-determination, and the new concepts of quality of life,
are leading to consensual medical treatment and to written
consents [28].
However, SOFA alone does not provide sufficient comple-
mentary information about the possible need to withdraw
treatment, in particular when referring to the withdrawal of
life support. Beginning a treatment is easy, but stopping it
is much more difficult. The only analyzed data which may be
of interest in this sense are the number of days with a max-
imum SOFA score despite an elevated TISS score. This
could be considered as a sign of diagnostic or treatment
failure.
In this sense, although it may be very difficult to accept a
`feeling of failure' [29], the data afforded by daily TISS and
SOFA may be very useful. Our study suggested that a
patient suffering from the failure of six organs together with
a SOFA score above 16 inexorably evolved to death. These
data were reinforced when the increase in the patient's
SOFA score was accompanied by an equally significant
increase in the TISS. The worsening of the clinical situation
was maintained despite the additional therapeutic
resources used.
Undoubtedly, the withdrawal of life support reduces both
ICU stay and the investment of therapeutic resources
(lower accumulated TISS), which has corresponding
economic repercussions. However, this reduction was not
statistically significant among the patients in the DWH and
DIH groups.
Table 3
Indicators of severity according to the final outcome
Final outcome S DH DIH DWD DWH BD CVD
Number of cases 301 2 13 9 25 20 2
ICU stay (days)* 7 24 20 12 14 5 4
APACHE III† 38 81 91 81 84 91 41
SOFA on first day† 4 12 10 9 9 9 2
Mean SOFA† 3 7 8 11 12 11 4
Maximum SOFA† 4 12 11 15 15 13 6
Days at max SOFA‡ 2 4 3 5 2 2 1
Accumulated SOFA§ 31 182 168 139 161 65 11
TISS on first day# 22 37 34 24 34 34 15
Mean TISS¶ 21 38 31 33 37 35 21
Accumulated TISS** 185 914 632 396 516 207 66
S, survivors at 1 year; DH, death at home; DIH, death in the hospital once discharged from intensive care unit (ICU); DWD, death after the 
withdrawal of therapeutic life support measures; DWH, death after withholding of life support; BD, brain death; CVD, cardiovascular death. *The 
length of the ICU stay was significantly longer in the DWH and DIH groups than in the S and BD groups. †The APACHE III, sepsis-related organ 
failure assessment (SOFA) at the first day, mean SOFA and maximum SOFA scores were significantly smaller in the S group compared with the 
rest of the groups. ‡The number of days with a sustained maximum SOFA score was significantly higher in the DWD group than the S group and 
also greater than the BD and DWH groups, although this was not statistically significant. §The accumulated SOFA score was significantly greater 
in the DIH, DWH and DWD groups. #The therapeutic intervention scoring system (TISS) score at the first day was significantly higher in the DIH, 
DWH and BD groups. ¶The mean TISS score was significantly smaller in the S group. **The accumulated TISS score of the DIH and DWH groups 
showed statistically significant differences in relation to the S and BD groups.Page 5 of 7
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group were in fact subject to therapeutic restrictions from
the moment of admission. This can be explained by the fact
that, with similar levels of severity (APACHE III and SOFA
score on the first day), the TISS score on the first day was
lower than in the other groups of deaths. Despite this, the
mean TISS was very similar. It was surprising to note that,
during ICU stay, an increase of resources used was
observed for the DWD group which, in the end, reached
the mean for the other groups of deaths.
Another noteworthy finding was the length of time that
elapsed from the beginning of therapeutic restrictions until
the decision to withhold life support. It was shown that
patients in whom life-support measures were withheld had
previously passed an average of 5 days with constantly
high SOFA levels. This may be seen as a worryingly long
period when costs and the optimal use of scarce resources
are considered. It should also not be forgotten that, during
this period, the patient is dying. It is not easy to define the
`best moment' to withdraw life-support measures without
overextending an `agonizing state' that leads to discomfort
for the patient or the family. The withdrawal of all life-sup-
port measures except for mechanical ventilation may mean
that the patient is maintained in a terminal situation for some
time. If this situation is maintained for a few minutes or even
hours it may facilitate contact between the patient and the
family during the last moments, but if prolonged for more
than a night or for days, it generates significant anxiety
among both the family and the team caring for the patient
[29].
In the DIH group, both the average and maximum SOFA
scores were lower when compared with the other groups
of deaths. The longer stay and higher accumulated TISS in
this group are justified by an improvement in the severity
markers, which enables these patients to be discharged
from the ICU. However in these cases, the decision to dis-
charge is usually accompanied by a specific order not to
readmit in case of a new downturn in the patient's
condition.
All these aspects imply cultural and social factors that
should be respected. With time, new social and cultural
factors will appear which will modify our behavior in these
situations. These cultural changes cannot be expected to
be equal for different countries, religions, social spheres,
etc.
Finally, we should not forget that the parameters analyzed
can also be used to evaluate the protocols used in each
unit, and to help us determine in which cases extraordinary
actions or research protocols should be considered. They
may also lead to a better use of our resources.
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